Latest News & Updates
Breaking News
2 hours ago
Vaibhavi M.
Other trending news you may like to read
Praxis Announces Positive EMBRAVE Trial Results Showing Significant Seizure Reduction With Elsunersen In Pediatric SCN2A Epilepsy
Praxis Precision Medicines, Inc. reports positive Phase 1/2 EMBRAVE trial results with elsunersen, showing significant seizure reduction in pediatric SCN2A epilepsy patients.
Vaibhavi M.
ImmunityBio Addresses FDA OPDP Concerns, Strengthens Compliance And Clarifies ANKTIVA Promotional Communications
ImmunityBio, Inc. addresses FDA OPDP concerns on ANKTIVA promotions, removes podcast content, and strengthens compliance measures to ensure accurate communication of approved indications.
Vaibhavi M.
Medicus Pharma Submits Optimised Phase 2 Trial Design For Teverelix To Address Unmet Need In BPH-Related Urinary Retention
Medicus Pharma Ltd. submits optimized Phase 2 trial design to FDA for Teverelix, targeting prevention of recurrent urinary retention in patients with benign prostatic hyperplasia.
Vaibhavi M.
IDEAYA Biosciences Advances Solid Tumour Treatment, First Patient Dosed In IDEAYA’s IDE574 Trial, Exploring Novel Epigenetic Therapy For Resistant Cancers
IDEAYA Biosciences, Inc. doses first patient in Phase 1 trial of IDE574, a dual KAT6/7 inhibitor targeting solid tumors including breast, prostate, colorectal, and lung cancers.
Vaibhavi M.
